KARA, O.; ACAR, S.; ELIBOL, T. . The importance of intermediate-dose Valacyclovir in primary CMV prophylaxis after Allogeneic-stem cell transplantation, and the advantages of step-wise pre-emptive treatment in CMV reactivation. Medical Science and Discovery, [S. l.], v. 9, n. 6, p. 324–333, 2022. DOI: 10.36472/msd.v9i6.743. Disponível em: https://medscidiscovery.com/index.php/msd/article/view/743. Acesso em: 17 apr. 2024.